The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

A phase 2b study evaluating repibresib gel in nonsegmental vitiligo did not meet its primary endpoint and an ongoing ...

V Foundation for Cancer Research has named Diana Hargreaves, PhD, a 2025 All-Star Translational Award Program grantee, ...

U.S. officials have rejected proposed amendments to WHO’s International Health Regulations citing concerns over vague wording ...

Once-weekly tirzepatide conferred a similar cardiovascular risk as once-weekly dulaglutide in adults with type 2 diabetes and ...

In this Healio Video Perspective from the American Society of Retina Specialists annual meeting, Sunir J. Garg, MD, FACS, ...

Daily doses of obicetrapib over 52 weeks led to significant reductions in plasma p-tau217 and other Alzheimer’s disease ...

Last winter, I donated my kidney to a stranger. As a nephrologist, I see people every day who need a gently used kidney, and ...

AbbVie released positive topline data from its phase 3 UP-AA trial demonstrating safety and efficacy for upadacitinib for ...

Exercise-based cardiac rehabilitation may improve symptom burden, exercise capacity and health-related quality of life for ...

Patients receiving prolonged mechanical ventilation discharged from the ICU had better outcomes related to 6-month mortality ...

Patients with type 2 diabetes are more likely to experience adverse financial outcomes such as having a low credit score, ...